Pharmaceutical development provider CoreRx announced today it will be hiring top candidates in the areas of preformulation and formulation development. CoreRx will also increase headcount in analytical, manufacturing and client logistics, strengthening their commitment to customer first service excellence.
CoreRx, fast becoming a world-recognized leader in early drug contract development, was announced today as one of Tampa Bay’s Fast 50 companies. The Tampa Bay Business Journal’s Fast 50 is a list of the fastest growing privately held companies in Tampa Bay over a span of three years. Last year, CoreRx was recognized as the 6th fastest growing company in the Tampa Bay region.